Lumibird Medical Launches New Website Dedicated to Laser Therapies for Each Glaucoma Stage

Lumibird Medical announced the launch of its new website: www.glaucoma-laser-assisted-solutions.com, which details the treatment options at every stage of the disease paradigm:

1. SLT - A first-line treatment for glaucoma: SLT is a unique, non-destructive and repeatable laser therapy, reducing IOP in patients with primary open angle glaucoma. The LIGHT study, published in 2019, confirms SLT as a first line treatment, delivering efficacy and some cost saving benefit to patients. The study demonstrated an improvement in quality-of-life survey in contrast to other therapeutic options.

2. SUBCYCLO – A second-line therapy for glaucoma: SubCyclo is a subthreshold laser-therapy for the treatment of glaucoma. Based on the transscleral cyclophotocoagulation principle, SubCyclo stimulates the ciliary body with an intermittent 810nm laser wavelength, resulting in a reduction of aqueous humor production, while also remodelling the uveoscleral pathway, to provide an improved secondary route of aqueous outflow.

3. THERMOCYCLO – A last resort therapy for glaucoma: A well-established transscleral laser treatment modality indicated for refractory glaucoma patients. Transscleral photocoagulation of the ciliary processes reduces overall production of aqueous humor.

In order to promote a better understanding of these laser technologies and their clinical applications, Lumibird Medical has created the www.glaucoma-laser-assisted-solutions.com website, as a concise repository where clinical evidence and best practice resources can be easily accessed online. The website is available in English, with a Spanish edition to follow in April.